The use of biodegradable PGA stents to judge the risk of post-TURP incontinence in patients with combined bladder outlet obstruction and overactive bladder.
about
Usefulness of biodegradable stents constructed of poly-l-lactic acid monofilaments in patients with benign esophageal stenosisClinical relevance of urethral stents (Urospiral 2™) placement in patients with prostatic obstacle and concomitant high-risk surgical status or neurological diseases: a feasibility and safety study.Critical appraisal of the Spanner™ prostatic stent in the treatment of prostatic obstruction.Temporary prostatic urethral stenting as a provocative tool to determine surgical eligibility in complex bladder outlet obstructed patients: our initial experience.Endoscopic submucosal dissection combined with the placement of biodegradable stents for recurrent esophageal cancer after chemoradiotherapy.
P2860
The use of biodegradable PGA stents to judge the risk of post-TURP incontinence in patients with combined bladder outlet obstruction and overactive bladder.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
The use of biodegradable PGA s ...... uction and overactive bladder.
@en
The use of biodegradable PGA s ...... uction and overactive bladder.
@nl
type
label
The use of biodegradable PGA s ...... uction and overactive bladder.
@en
The use of biodegradable PGA s ...... uction and overactive bladder.
@nl
prefLabel
The use of biodegradable PGA s ...... uction and overactive bladder.
@en
The use of biodegradable PGA s ...... uction and overactive bladder.
@nl
P2093
P1433
P1476
The use of biodegradable PGA s ...... uction and overactive bladder.
@en
P2093
Christer Dahlstrand
Silas Pettersson
Tomas Knutson
P304
P356
10.1016/S0302-2838(02)00314-7
P407
P577
2002-09-01T00:00:00Z